Cel Sci Corporation (CVM)

[sushifishman]

EF Hutton Assumes CEL-SCI at Buy, Announces Price Target of $10

Last week Geert Kersten chatted with EF Hutton. Hutton issues a Buy and PT of $10. From the report:


“We are assuming coverage of CEL-SCI from Tim Moore, CFA, maintaining a Buy rating, and adjusting the price target to $10. This morning, we had the opportunity to speak with Chief Executive Officer and director, Geert R. Kersten, J.D., post the F1Q23 business update. We were able to have a discussion regarding the next steps toward a BLA filing for Multikine in resectable head and neck squamous cell carcinoma. Internal validation of the manufacturing facility located outside of Baltimore most likely will not be completed until 2H2023. Steps continue to be taken to ensure all chemistry, manufacturing, and control processes for what is being characterized as a “complex molecule” may be “inspection ready.” Further, the “pre-BLA” meeting has not yet been scheduled. Management would like to have the manufacturing facility closer to internal validation standards before reaching out to the regulatory authorities."

No pre bla meeting after 21 months
No certified facility after 21 months
BLA filing in 2024. Nearly 3 years later

But. But….3 posters to put on a wall.

Woof!

All the while, GK receives $1M in compensation a year

Moderators: Please make this a sticky

Cheers